Autopsy report · NCT03073369

Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Study didn't materialize for various reasons.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 4
Sponsor: University of Alabama at Birmingham
Sponsor type: University, hospital or other
Conditions: CKD; Chronic Kidney Diseases; Hepcidin; Ergocalciferol; Vitamin D; Iron-deficiency
Interventions: Ergocalciferol 50000 UNT; Placebo
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.